Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intraoperative radiotherapy: current thinking.

V Valentini1, M Balducci, F Tortoreto

  • 1Department of Radiotherapy, Institute of Radiology, Rome, Italy. vvalentini@rm.unicatt.it

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|March 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Image-guided interventional radiotherapy (modern brachytherapy) for treatment of vaginal intraepithelial neoplasia: single-institution experience and systematic literature review and meta-analysis.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026
Same author

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

ESMO real world data and digital oncology·2026
Same author

READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinoma.

ESMO real world data and digital oncology·2026
Same author

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial.

ESMO open·2025
Same journal

Refining oncological resectability for intrahepatic cholangiocarcinoma: Radiological assessment of mediastinal lymph node enlargement does not reflect clinical prognosis after curative resection.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Macroscopic venous tumour thrombus in paediatric adrenocortical tumours.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Outcomes after pulmonary bilobectomy for NSCLC: The role of surgical type, indication, and pulmonary function.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Impact of 18-FDG PET-CT on the preoperative staging and management of Incidental Gall Bladder Cancer (IGBC)- A prospective study from a tertiary care centre in North India.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Association of clinical response and lymph node yield with prognosis after neoadjuvant therapy for esophageal squamous cell carcinoma.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same journal

Indication-specific use of Denosumab in Giant Cell Tumour of Bone: A retrospective cohort study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
See all related articles

Intraoperative radiotherapy (IORT) delivers a large radiation dose during surgery to improve tumor control. Clinical studies show IORT enhances local control and survival for various cancers when combined with other treatments.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Surgical Oncology

Background:

  • Intraoperative radiotherapy (IORT) involves delivering radiation during surgical procedures.
  • The primary aim is to enhance locoregional tumor control by delivering a high radiation dose to a defined surgical area.
  • IORT is frequently integrated as a boost radiation component in multidisciplinary cancer treatment protocols.

Purpose of the Study:

  • To summarize the role and outcomes of intraoperative radiotherapy in cancer treatment.
  • To highlight the potential benefits of IORT in improving tumor control and patient survival.

Main Methods:

  • Delivery of a large single radiation dose directly to the tumor bed during surgery.
  • Utilizing advanced techniques and mobile equipment to facilitate IORT procedures.

Related Experiment Videos

  • Integration of IORT within multidisciplinary treatment strategies for various malignancies.

    • Main Results:

    • Clinical experience indicates that IORT can improve local tumor control.
    • IORT has demonstrated potential to enhance disease-free survival.
    • These benefits are particularly noted when IORT is used in the adjuvant setting, combined with external beam irradiation.

    Conclusions:

    • Intraoperative radiotherapy is a valuable technique for improving locoregional tumor control.
    • IORT shows promise in enhancing survival outcomes for specific cancers, including stomach, pancreas, colorectum, and soft tissue sarcoma.
    • The integration of IORT into adjuvant therapy regimens warrants further investigation and application.